Bpifrance

Bpifrance Financement S.A. is a French financial institution that provides a range of financing solutions and support services aimed at fostering the growth of startups, small and medium-sized enterprises (SMEs), and mid-cap companies. It offers various financial products, including medium to long-term loans, export insurance, and leasing options for both tangible and intangible assets. Additionally, Bpifrance supports companies through consulting services, guarantees for bank financing, and training for executives. The organization also engages in direct investments and manages funds aimed at enhancing the financial landscape for businesses at different stages of their development. Established in 1980 and based in Maisons-Alfort, France, Bpifrance was formerly known as OSEO S.A. and rebranded in July 2013. It operates as a subsidiary of Bpifrance SA, reinforcing its commitment to bolstering the French economy through diversified financial solutions.

Céline André

Investment Director

Adonis Arnaud

Junior Investment Manager

Laurent Arthaud

Managing Director

Françis Aymard

Investment Director

Simon Beauroy

Director

Isabelle Bebear

Director for International and University

Soukanda Bentaleb

Investment Officer

Denis Biju-Duval

MD of Mezzanine division

Stéphane Boivert

Associate

Pascal Bordat

Investment Director

Charles-Henri Boyer

Associate

Émilie Brunet

Investment Director and Portfolio Manager

Caroline Butin-Gelineau

Senior Investment Director

Nathalie Carmona

Associate

Yoann Caujolle

Portfolio Director

Jocelyne Cerasa

Investment Director

Nicolas Ceria

Associate

Ménelé Chesnot

Senior Investment Director

Maufras Du Chatellier, Elyssa

Investment Director

Samuel Dalens

Investment Director

Florent Debienne

Managing Director | Head of Technology Funds Investments

Christian Deblaye

Deputy MD

Grégoire Delpit

Portfolio Director

Luc Doyennel

Investment Director

Nicolas Dufourcq

CEO

Jean-Yves Duriez

Investment Director

Antoine Emmanuelli

Partnership Director

Francis Estellat

Senior Investment Director

Yannick Etienne

Investment Manager

Alain Fakhoury

Investment Director Bretagne

Stephen Fargis

Associate

Arnaud Fauquembergue

Investment Manager

Olivier Fosse

Investment Director Alsace Champagne-Ardenne Lorraine

Jean-Marie Fougeray

Investment Director Bretagne

Stéphanie Frachet

Investment Director

Ronan Frefield

Portfolio Director

Marie-Laure Garrigues

Investment Director

Laurence Gauthier

Senior Investment Director Bourgogne Franche-Comté

Xavier Gelot

Director of Fonds de Renforcement des PME

Emmanuelle Gervais

Senior Investment Director

Isabelle Ginestet-Naudin

Deputy MD and Director of Sectorial Funds

Vanessa Giraud

Managing Director

Alessandro Gonella

Director

José Gonzalo

Executive Director Mid and Large Cap Direction

Jean-Michel Grau

Office and Institutional Relations MD

Alexis Guinard

Investment Director

Raphaël Guterman

Associate

Yonel Génin

Partnership Director

Luc Heinrich

MD

Hubert Hernandez

Investment Director

Hortense Jacon

Investment Associate

Véronique Jacq

Managing Director

Jean-René Jégou

Director of the Regional Funds Department

Pascal Lagarde

Director

Caroline Lebel

Senior Associate

Eric Lefebvre

Director

Ronan Lefort

Investment Director

Arnaud Legardeur

Investment Director

Benjamin Legourd

Investment Manager

Christian Leonetti

Investment Director

Olivier Levy

Director of East private equity Interregional Network

Martin Lochon

Associate

Cedric Lowenbach

Director of Operations

Arielle Marsaud

Associate

Alex Marvaldi

Partner

Laure Michel

Investment Director

Maud Moulin

Portfolio Director

Sébastien Moynot

Investment Director and Member of the Management Board

Philippe Mutricy

Deputy MD

Valérie de la Ménardière

Investment Director

Marinus Oosterbeek

Associate

Alexandre Ossola

MD

Stanislas Panhard

Senior Investment Director

Nicolas Parpex

Senior Investment Director

Emeline Parry

Investment Manager

Sophie Perette

Portfolio Director Alsace Champagne-Ardenne Lorraine

Thibault Peroys

Investment Director

Dominique Phelouzat

Incharge of Administration and Finance, CFO

Axel Piriou

Senior Investment Manager

Marc Prévôt

Director of North Private Equity Interregional Network

Matthieu Rabeisen

Portfolio Director

Sarah Roeland

Investment Manager

Stéphane Romang

Investment Director

Thibaut Roulon

Investment Director

Julie Régnier

Senior Investment Manager Alsace Champagne-Ardenne Lorraine

Eduardo Sampaio

Portfolio Director

Nadia Sarri

Investment Director

Gilles Schang

Deputy Managing Director

Nicolas de La Serre

Investment Director Pays de la Loire

Nicolas Sluys

Associate

David Smadja

Investment Manager

Thierry Sommelet

MD

Vincent Stievenard

Investment Director and Director of North Private Equity Interregional Network

Jonathan Szalavecz

Associate

Xavier Tessier

Director

Gabrielle Tetart

Senior Investment Manager and Associate

Tuan Tran

Investment Director

Alain Tueux

Investment Director

Stanislas de Tymowski

Associate

Adrien Vasseur

Portfolio Director

Luc Vernhet

Associate

Benoît Villain

Senior Investment Manager

Philippe Vuarchex

Associate

Stéphanie Vuillaume

Associate

Romain Vérani

Associate

Samuel Waddell

Associate

Tristan de Witte

Associate

Le Mintier Jonglez, Delphine

Investment Director

de Saint Lager, Benoist

Investment Director

Galamand Patard, Isabelle

Director

889 past transactions

Expliseat

Venture Round in 2023
Expliseat combines innovation and manufacturing performance in the lightest aircraft seat in the world: the Titanium Seat. At just 4 kg, this seat reduces fuel consumption considerably, resulting in savings of up to $500,000 per plane per year. And with 10 patents, the Titanium Seat also provides passengers with greater comfort and 2 inches more room, thanks to its unique ergonomic design.

Alentis Therapeutics

Series C in 2023
Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.

Odimma

Seed Round in 2023
Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

EyeLights

Series A in 2023
EyeLights SAS is a French company that specializes in designing and manufacturing GPS-enabled motorcycle helmets. Founded in 2016 and based in Labege, EyeLights offers a unique head-up display that projects navigation, warnings about hazards, and traffic information directly into a rider's line of sight, allowing them to maintain focus on the road. The system integrates with smartphones via Bluetooth, enabling users to listen to music, take calls, and program road trips using voice commands. The compact device can be installed in under five minutes on various helmet types and operates for over eight hours, providing clear visibility even in challenging weather conditions. Weighing less than 100 grams, the EyeLights product is designed for practicality and ease of use, enhancing the overall riding experience.

Kiro

Series A in 2023
Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.

Exotrail

Series B in 2023
Exotrail SA, founded in 2015 and based in Palaiseau, France, specializes in developing electric propulsion systems and flight software for small satellites and their constellations. The company offers ExoMS, an innovative propulsion system designed to enable small satellite constellations to reach new orbits, and ExoOPS, a cloud-based software that aids engineers in designing and planning satellite missions. Exotrail's electric thrusters, specifically tailored for nano and micro-satellites, are utilized in various applications, including telecommunications, earth observation, and scientific research. The company's technology aims to create agile satellite constellations that enhance capabilities in these critical areas.

Dianosic

Seed Round in 2023
Dianosic SAS owns and operates a health care organization. The company designs and develops CAVI-T, an asymmetrical intranasal balloon which stops spontaneous or postoperative bleeding hemostasis with low-pressure compression, adapting to the unique anatomy of the nasal cavity; active asymmetric balloon that helps to avoid the formation of biofilm, kill specific bacteria or accelerate healing; and asymmetric balloon equipped with sensors. Also, it develops an Active Resorbable Intranasal Scaffold device that treats sinusitis sufferers after the failure of conventional drug treatment. The company was founded in 2017 and is headquartered in Strasbourg, France.

Garantme

Series B in 2023
Garantme is a broker specializing in insurance and banking services, primarily focused on providing rent guarantees in France. Established in 2017 and headquartered in Saint-Ouen, the company offers solutions that protect rental income for landlords through solvency and partner insurances. In addition to its guarantee services, Garantme features a platform called Garantme search, which assists clients in finding suitable accommodation. The company specifically caters to a diverse clientele, including international students, by guaranteeing their leases and enhancing their rental applications.

ATAWEY

Private Equity Round in 2023
ATAWEY SAS designs and manufactures autonomous energy solutions for isolated sites. Its product consists of a short term storage system (day) with batteries, and a long term storage system (year) with a hydrogen chain installed outdoors. The company’s system achieves total electrical autonomy for a site over a year, as well as resists to demanding weather conditions and to act of vandalism. It offers its solutions for isolated industrial sites, isolated tropical housing, isolated temperate housing, and isolated sites requiring occasional and seasonal energy supplies. The company was founded in 2012 and is based in Le Bourget-du-Lac, France.

Pasqal

Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

Welinq

Pre Seed Round in 2023
WeLinQ is a quantum computing solution interconnecting processors.

Agenium

Venture Round in 2023
Agenium provides simulation solutions for space industry, aeronautics, defense and security.

MYCOPHYTO

Venture Round in 2023
SAS MYCOPHYTO develops biological solutions to revitalize the soil and accelerate the development of plants. The company analyses soil and isolates, multiplies, and inoculates mycorrhizae on plantation. SAS MYCOPHYTO was founded in 2016 and is based in Mougins, France.

Odaptos

Seed Round in 2023
Odaptos designs and markets a SaaS product to perform usability testing in videoconferencing, analyze human emotions, and provide results and insights to understand the end-users. It is an artificial intelligence platform that allows users to perform usability testing.

45-8 Energy

Seed Round in 2022
45-8 Energy SAS is a company based in Metz, France, focused on the exploration and production of helium. Founded in 2017, it specializes in eco-friendly helium extraction and operates various helium exploration projects. The company also provides oil and gas consulting services, aiming to support businesses in accessing local helium supplies. By conducting subsurface exploration and research, 45-8 Energy seeks to develop a sustainable helium supply chain in the European market, which may help reduce the environmental impact associated with traditional helium sourcing.

Kumulus Water

Pre Seed Round in 2022
Kumulus machines create drinking water from solar power and air by imitating the dew phenomenon in the water creation process and adding elements such as multiple embedded systems/predictive algorithms to allow for the machines to be “smarter” and controllable remotely from anywhere in the world.

Guerbet

Post in 2022
Guerbet is a human-scale company that aims to become a new global leader in medical imaging. Pioneer in contrast media with 90 years'​ experience, Guerbet is the only pharmaceutical group dedicated to medical imaging worldwide, with a presence in almost 80 countries via a network of subsidiaries and distributors. The company offers a comprehensive range of CT scan, Cath Lab, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostic (IRT) products, along with a range of injectors and related medical devices to improve patients'​ diagnosis, prognosis and quality of life.

ChapsVision

Venture Round in 2022
ChapsVision specializes in providing a data analysis platform that addresses complex business challenges for sectors with significant data footprints, such as Retail, Finance, and Public Services. The company offers a comprehensive suite of business solutions that are fully integrated around a unified Customer and Product repository. This modern analytical infrastructure equips clients with intelligence, investigation, and analysis tools that consolidate data from various sources into a single workspace. By doing so, ChapsVision supports its customers in effectively navigating and optimizing their digital transformation processes.

Devialet

Venture Round in 2022
Devialet SAS is an audio technology company based in Paris, France, founded in 2007. It specializes in hybrid amplification technology that combines analog and digital elements to enhance audio devices. The company offers a range of products, including wireless earbuds, speakers, and amplifiers, as well as solutions for vinyl playback. Devialet aims to make its audio technology universally accessible and has developed products such as the Gemini wireless earbuds. Its offerings are available for purchase online and through various dealers and retail locations both in France and internationally.

Shortcut

Grant in 2022
Saas

Apmonia Therapeutics

Venture Round in 2022
Apmonia Therapeutics developing a pipeline of next generation peptide based therapies targeting the tumor microenvironment to improve the lives of patients with cancer. If anyone would want to contact them please contact them via phone call or email.

Contentsquare

Series F in 2022
Contentsquare offers a platform that analyzes customer behavior through billions of anonymous interactions across web, mobile, and app environments, while adhering to data privacy regulations such as the EU GDPR and California CCPA. The platform synthesizes various data points, including content, user experience, product details, pricing, acquisition channels, and technical performance, to generate insights and AI-driven recommendations. These insights aim to enhance digital performance throughout the customer journey, ultimately helping businesses improve revenue, engagement, and growth. With a client base exceeding 700 enterprise customers, Contentsquare serves notable companies such as American Express, Best Buy, Dell, Ikea, LVMH, T-Mobile, Salesforce, Sephora, and Toyota.

Ludocare

Seed Round in 2022
Ludocare focuses on developing therapeutic robots that assist patients with chronic diseases and their families. The company's innovative devices are designed to complement traditional drug treatments by providing personalized support that enhances treatment efficiency. By empowering patients, especially children, Ludocare aims to improve therapeutic compliance both quantitatively and qualitatively. This approach facilitates better disease management and helps stabilize essential treatments, ultimately contributing to improved autonomy and quality of life for patients and their families.

Edaphos

Venture Round in 2022
Edaphos is an international holding company providing eco-friendly soil remediation solutions to transform waste and barren soil into fertile soil.

Flying whales

Venture Round in 2022
Flying Whales is a French company founded in 2012, headquartered in Suresnes. The company specializes in an innovative aeronautic program designed for the transportation of heavy and oversized loads, effectively connecting land-locked regions to the global economy. Its approach aims to provide efficient logistics solutions for challenging transport needs, enhancing accessibility and fostering economic growth in various sectors.

Siteflow

Series A in 2022
Siteflow is a developer of cloud-based service management software tailored for complex industries such as nuclear, manufacturing, special works, and oil and gas. Established in 2017 and headquartered in Paris, France, the company offers Siteflow Builder, an application designed to streamline operations, ensure timely execution of tasks, track project status, and assess performance on work sites. The software facilitates collaboration among colleagues and standardizes business operations, addressing the unique challenges of regulated industries where traditional methods have remained unchanged for decades. By focusing on user-friendly interfaces and functionalities, Siteflow aims to enhance user acceptance and ease the digital transformation process. Additionally, the company supports organizations in redesigning their workflows to achieve operational excellence, helping professionals to focus on critical tasks while improving overall efficiency through real-time monitoring and automated reporting.

Osivax

Grant in 2022
​Osivax is a developer of immunotherapy vaccines intended to facilitate the treatment of infectious diseases. The company's vaccines expedite the uptake into dendritic cells and increase the immunogenicity of the natural protein to trigger a more effective immune response, including an unprecedented CD8 T cell activation, enabling medical practitioners to treat patients with cancer as well as influenza, malaria and other infectious diseases effectively.

Strapi

Series B in 2022
Strapi Solutions SAS is the developer of Strapi, an open-source content management framework built on Node.js that enables developers to create and manage APIs efficiently. Founded in 2016 and based in Paris, France, Strapi offers a headless CMS that separates the backend from the frontend, allowing developers to choose their preferred tools and frameworks for application development. The platform supports various use cases, including blogs, brand websites, and product catalogs, while providing a powerful dashboard for API management. Additionally, Strapi offers consulting and training services to assist customers in optimizing their use of the platform. With a focus on flexibility and ease of use, Strapi serves a global clientele, empowering developers to build robust back-end solutions with minimal effort.

Leanspace

Seed Round in 2022
Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources. Leanspace brings a new way to build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness. Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!

Leanspace

Debt Financing in 2022
Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources. Leanspace brings a new way to build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness. Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!

Scintil Photonics

Venture Round in 2022
Scintil Photonics SAS, founded in 2018 and based in Grenoble, France, specializes in the development of silicon photonic integrated circuits aimed at advancing high-speed optical communications and chip interconnections. The company offers a range of products, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. By employing wafer-scale bonding techniques that combine Silicon and Indium Phosphide materials, Scintil Photonics creates fully integrated circuits that enhance performance and reliability while significantly lowering implementation costs. Their innovative approach allows for the monolithic integration of optical amplifiers and lasers on advanced silicon photonic circuits, making their solutions suitable for a variety of industrial applications.

DCbrain

Venture Round in 2022
DCbrain offers a solution designed to assist teams managing data centers in optimizing their operations. By utilizing graph models and machine learning, the company provides a comprehensive view of the systems within data centers, showcasing a dynamic map of various flows, including energy and chilled water. Additionally, DCbrain features expert dashboards that facilitate the exploitation and maintenance of complex industrial networks, encompassing sectors such as gas, water, electricity, and logistics. This approach aims to improve efficiency and streamline processes for data center operations.

DBV Technologies

Post in 2022
DBV Technologies S.A. is a clinical-stage biopharmaceutical company focused on the research and development of epicutaneous immunotherapy products aimed at treating food allergies. The company’s lead candidate, Viaskin Peanut, has completed Phase III clinical trials for peanut allergies in children, adolescents, and adults. Additionally, DBV is developing Viaskin Milk, which is in Phase I/II trials for cow's milk protein allergy and related conditions, and Viaskin Egg, which is in pre-clinical stages for hen’s egg allergy. The company is also working on a booster vaccine for Bordetella pertussis, along with earlier-stage research programs targeting respiratory syncytial virus, Crohn’s disease, celiac disease, and type I diabetes. DBV Technologies collaborates with Nestlé Health Science to create MAG1C, a diagnostic patch test for non-IgE mediated cow's milk protein allergy in infants and toddlers. Founded in 2002, the company is headquartered in Montrouge, France.

Diabeloop

Debt Financing in 2022
Diabeloop SAS is a medical device company based in Grenoble, France, specializing in the development of an electronic artificial pancreas designed for individuals with Type 1 diabetes. Established in 2015, the company has created a closed-loop system that integrates a continuous glucose sensor and a smartphone-like terminal to monitor glycemia levels. This system communicates with a connected insulin pump to determine and deliver the optimal amount of insulin, aiming to reduce the risks of hypoglycemia and other complications associated with diabetes. Diabeloop's mission is to provide innovative technological solutions that empower individuals with Type 1 diabetes to manage their condition effectively and enhance their quality of life.

Vade Secure

Venture Round in 2022
Vade Secure SASU specializes in email security software, providing protection against phishing, spear phishing, malware, and ransomware. The company's offerings include solutions such as Vade Secure for Office 365, Isltphishing threat detection for security operations centers, and enterprise cloud and gateway services. Vade Secure employs heuristic filtering to analyze incoming emails in real-time, effectively identifying and neutralizing threats, including zero-day attacks. Additionally, the company manages low-priority emails through its Graymail Management feature, which organizes non-essential communications into a separate folder. Founded in 2008 and headquartered in Hem, France, Vade Secure serves a diverse range of sectors including international shipping, original equipment manufacturers, hosting companies, and enterprises. With a presence in five countries—USA, Canada, France, Hong Kong, and Japan—Vade Secure supports over 500 million mailboxes in 76 countries, ensuring round-the-clock assistance for its clients.

Nutripure

Private Equity Round in 2022
Nutripure is a Digital Native Vertical Brand (DNVB), which develops and distributes food supplements and organic superfoods.

SENCROP

Series B in 2022
Sencrop is an ag-tech startup that offers an in-field data-based platform to empower farmers to make better decisions in their daily agricultural activities. Sencrop designs and sells connected weather forecast solutions for farmers to measure rain, hygrometry, and wind speed. The sensors are cheap, robust, movable, and easy to use, making more efficient and sustainable farming possible

Arianee

Series A in 2022
Arianee SA, founded in 2018 and based in Paris, France, specializes in providing digital certifications for products. The company has developed an Ethereum-compatible blockchain platform that modernizes the authentication process for branded products through a universal open-source protocol. This platform enables the recording of all elements involved in the creation and sale of products in an immutable ledger, ensuring that the data remains unalterable, deletable, or subject to shutdown. By doing so, Arianee facilitates collaboration among brands, owners, and third-party retailers, promoting a global standard for the digital certification of valuable items.

Implicity

Series A in 2022
Implicity is a developer of a remote monitoring platform that enables the smart monitoring of patients with connected pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on each patient's medical context. This innovative approach allows cardiologists and healthcare professionals to automate the remote monitoring process, consolidating patients' telepulse information into a single platform. By enhancing the efficiency of monitoring, Implicity aims to support hospital teams in delivering optimal quality care to their patients.

Handivoyage

Series A in 2022
Handivoyage SAS operates an online travel booking platform specifically designed for individuals with disabilities. Founded in 2016 and based in Lyon, France, the company offers a variety of services, including holiday and hotel bookings, as well as access to medical equipment, medical aid, and adapted transportation. Committed to continuous improvement, Handivoyage actively collects customer feedback through comprehensive questionnaires following each stay, allowing them to enhance their service quality. This focus on user experience is central to their mission of providing accessible travel options for people with disabilities.

Dfns

Seed Round in 2022
Xkey builds pure SaaS technology for digital asset security. We provide safe, cloud-native custody as a service that helps financial institutions—from startups to Tier-1 banks—transition to digital assets. It's a plug-and-play API allowing to add new assets to a portfolio and scale safely on a TSS-based institution-grade security infrastructure. Instead of using expensive, high maintenance, monolithic systems, we give access to a platform that gives our clients the freedom to release new products in days, while lowering total cost of ownership. Best-in-class, cryptographic security powered by a network of world-known Tier-1 custody banks. Plug-and-play, composable service flexibility. Continuous delivery, fast to deploy and integrate. Open API, fully-documented self-service environment. Asset agnostic support. ISO certified & compliant. Non-binding, transparent pricing. Global, agile and built for speed.

Umiami

Series A in 2022
Developer of a plant-based food technology designed to reduce meat consumption. The company's technology offers plant-based whole-cuts that contain plant proteins, enabling consumers to have alternatives that mimic the taste, texture, and smell of meat.

Umiami

Series A in 2022
Developer of a plant-based food technology designed to reduce meat consumption. The company's technology offers plant-based whole-cuts that contain plant proteins, enabling consumers to have alternatives that mimic the taste, texture, and smell of meat.

LimFlow

Series D in 2022
LimFlow System is approved for sale in markets regulated by the CE Mark. Investigational device in the United States. Limited by U.S. federal law to investigational use only in the U.S. LimFlow is a game-changing technology that enables clinicians to bring new hope to end-stage chronic limb ischemia (CLI) patients, when all other revascularization efforts have been exhausted. By restoring perfusion to the ischemic foot through a completely novel, percutaneous procedure, the LimFlow System can relieve ischemic pain, promote wound healing, reduce amputations and restore mobility for patients when used as part of a multi-disciplinary team approach.

Guard Medical

Series B in 2022
Guard Medical is the developer of NPseal™. We are an innovation driven company focused on creating easy-to-use and cost-effective solutions that enable prophylactic NPWT wound care of closed surgical incisions.

Priothera

Debt Financing in 2022
Priothera Ltd is a clinical-stage company focused on developing orally administered sphingosine 1 phosphate (S1P) receptor modulators aimed at treating haematological malignancies. Founded in 2020 and based in Dublin, Ireland, with an additional location in Saint Louis, France, the company seeks to improve patient outcomes by enhancing the curative potential of allogeneic hematopoietic stem cell transplantation. Its lead product, mocravimod, is designed to reduce the egress of specific T cell subsets from lymphatic tissues, thereby providing dual inhibition of graft versus host disease while promoting graft versus leukemia effects. Through this innovative approach, Priothera aims to deliver significant advancements in the treatment of patients with blood cancers.

Istya

Pre Seed Round in 2022
Istya develops solutions to monitor, predict and manage indoor air quality. Our solutions have also been designed to help reduce the energy cost of ventilation systems and limit the risk of spreading viruses by air. Istya was founded in 2021 and was headquartered in Ile-de-France, France.

Cairdac

Series A in 2022
Developer of a pacing device designed to maintain cardiac rhythm. The company's implanted leadless pacemakers incorporate a self-sustaining power patented technology harvesting the heart's kinetic energy and bringing disruptive technologies to conventional leadless pacemakers, enabling patients and healthcare professionals with cost-effective alternatives that will revolutionize patients' quality of life.

Deepki

Series C in 2022
Deepki SAS, founded in 2014 by Vincent Bryant and Emmanuel Blanchet, is a Paris-based company specializing in data analysis for energy efficiency. The firm focuses on identifying energy savings across numerous buildings simultaneously. By leveraging advanced data analytics, Deepki aims to optimize energy consumption and promote sustainable practices in the built environment.

Invivox

Series A in 2022
Invivox is an innovative online platform that connects medical professionals for practical, in situ training sessions, primarily in small groups or one-on-one settings. By facilitating these interactions among doctors worldwide, Invivox aims to enhance medical education and ultimately improve patient care. The platform not only offers interactive online classes but also publishes weekly medical magazines and curates specialized training opportunities in collaboration with a network of international experts. Through these initiatives, Invivox democratizes access to knowledge in the healthcare sector, providing valuable mentorship across various medical specialties.

Kayrros

Venture Round in 2022
Kayrros SAS is a leading data analytics company based in Paris, France, specializing in the energy markets. Founded in 2016, it focuses on enhancing investment decisions by integrating unstructured data, such as satellite imagery and social news, with financial and technical data. With a team of over 100 employees from more than 15 nationalities, Kayrros operates offices in Houston, London, New York, and Singapore. The company's advanced analytics solutions offer actionable insights in near real-time, providing transparency across the energy chain. Kayrros continually expands its product offerings to incorporate new geographies and data sources, helping global energy market players make informed decisions.

Vaxxel

Seed Round in 2022
Vaxxel is an Innovative viral live-attenuated platform that develops novel and proprietary live-attenuated vaccine candidates against bronchiolitis and pneumonia caused by pneumovirus.

Brenus Pharma

Seed Round in 2022
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.

Konect

Pre Seed Round in 2022
Konect is a software-as-a-service (SaaS) platform designed to serve the gaming community by enabling users to create personalized websites. The platform allows gaming enthusiasts to build their online profiles, connect with other gamers, and discover opportunities. Users can centralize all their online content, making it easy to share with their community. This streamlined approach not only fosters connections among gamers but also simplifies the process of sharing content and engaging with a wider audience.

K-Ryole

Series B in 2022
K-Ryole is a privately held company that manufactures smart electric bike trailer.

Archeon

Series A in 2022
Archeon is focused on creating innovative solutions for the monitoring, diagnosis, and treatment of critically ill patients in prehospital care. The company develops artificial intelligence-based technologies aimed at enhancing ventilation quality in emergency medical services. Its products are designed to be practical, user-friendly, and intuitive for emergency caregivers, providing real-time feedback on the quality of ventilation administered to patients. This approach aims to improve patient outcomes and support medical professionals in high-pressure situations.

Doctolib

Series F in 2022
Doctolib is an online booking platform and management software provider for doctors in Europe working with 65 000 health practitioners, present in 1 300 health facilities. 25 million patients visit Doctolib website and mobile app every month. For doctors, Doctolib is a full-range service to improve bookings management, reduce no-show and bring new patients to your office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctor or dentist appointments 24/24 and 7/7 within a few clicks. Founded in 2013, Doctolib is based out of Paris, France.

Alice & Bob

Series A in 2022
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company's innovative technology features self-correcting superconducting quantum bits, which allow for fault-tolerant quantum computing. This capability enables the execution of any quantum algorithm, thereby assisting industries and researchers in addressing complex challenges across various fields. By focusing on developing advanced quantum computing solutions, Alice & Bob aims to facilitate breakthroughs in solving significant problems in quantum research and industry applications.

Tenacy

Seed Round in 2022
Tenacy is a developer of cloud-based risk assessment and management software focused on enhancing cybersecurity processes across various organizational contexts. The platform enables businesses to assess and define risks, manage incidents and deviations, and create dashboards for performance measurement. It also offers benchmarking data and decision support tools, allowing organizations to integrate precise and customized cybersecurity governance. By providing a collaborative environment, Tenacy helps companies protect their assets and improve operational efficiency in managing cybersecurity challenges.

Kyotherm

Venture Round in 2022
Kyotherm SAS is an investment company based in Paris, France, that focuses on financing renewable heating and energy efficiency projects. Established in 2011, it provides project equity to support the development of energy infrastructure and acquires stakes in various renewable energy production initiatives, including geothermal and biomass heating plants, as well as district heating networks. Kyotherm collaborates with a range of stakeholders, including energy service providers, engineering firms, developers, heat consumers, and equipment manufacturers, to facilitate third-party financing for these projects.

INTERSTELLAR LAB

Seed Round in 2022
developing space-inspired villages on Earth

Lisaqua

Seed Round in 2022
Lisaqua is developing a unique aquaculture process to raise prawns without antibiotics and without polluting waste

Kubo Labs

Pre Seed Round in 2022
94 % of organizations have experienced a serious security issue in the last 12 months and cluster misconfiguration is the leading cause ("Kubernetes adoption, security, and market trends report" by Redhat, July 2021). For 68% of the organizations, Kubernetes-related bills are going up ("FinOps for Kubernetes", CNCF report, June 2021). With Kubo Labs, we make sure that won't happen thanks to a series of products that embedded best-practices.

Susu

Grant in 2022
Susu is a dynamic and innovative company that offers a wide range of health services for families in the African diaspora. Susu provides a complete offer on Preventive care, Medical treatments, Management of chronic diseases, and Authentic drugs.

CarbonWorks

Series A in 2022
CarbonWorks is specialising in the use of microalgae to capture and utilise carbon dioxide.

Cell-Easy

Funding Round in 2022
Cell-Easy SAS operates as a stem cell contract development and manufacturing organization (CDMO) that provides ready-to-inject adipose derived allogeneic stem cells for preclinical and clinical development projects. The company’s allogeneic production process allows using the biological material of a healthy donor to help thousands of patients. The company was incorporated in 2017 and is based in Toulouse, France.

Specify

Seed Round in 2022
Specify is a tool to create, scale and maintain a design system. Meet the ultimate bridge for digital product teams

Tracktor

Venture Round in 2022
Tracktor SAS is an online platform that facilitates the rental of construction equipment for professionals in the building and civil engineering sectors. Established in 2016 and headquartered in Paris, France, Tracktor enables users to quickly rent or borrow various construction tools through a user-friendly interface. The platform aggregates rental companies across France, allowing customers to receive instant quotes and advantageous rental conditions irrespective of their order volume. Users can efficiently book a range of equipment, including mini-excavators, platforms, trolleys, barriers, and living bases, all directly online.

Gouach

Seed Round in 2022
Gouach is a manufacturer of a revolutionary eco-designed battery that can be repaired at mega-speed.

Alma

Series C in 2022
Alma SAS owns and operates a payment platform for online businesses. It offers Alma, a platform that enables businesses to manage payments, accounting exports, and data analysis; and Multiple payment, a customer conversion solution for retailer selling to individuals. The company’s solution enables customers to make payment in various installments to start, then cash, and loans. Alma SAS was founded in 2018 and is based in Neuilly-sur-Seine, France.

Traxens

Venture Round in 2022
TRAXENS delivers the world's most exhaustive, precise and timely information on containers and container transporters allowing all stakeholders in multi-modal transport to improve costs, optimize investment, and offer premium services. To attain this performance TRAXENS led a 3-year R&D program to develop specific technology required to produce cost effective, durable and autonomous devices for a wide range of container data capture and real-time transmission of this data from anywhere on the globe.

Silvr

Series A in 2022
Silvr offers financial services to e-merchants who do not have access to bank credit and who have no vocation or desire to raise funds. Silvr's revenue-based financing is based on the performance of the companies they finance. Silvr supports entrepreneurs on the path to success.

Elicit Plant

Series A in 2022
Elicit Plant is an agro-biotech company specialized in crops’ water resistance and in the development of innovative phytosterol-based solutions.

Combo

Series A in 2022
Snapshift is a staff management web solution for restaurants. The company's software enables restaurant owners to make online scheduling and enter the information on contracts, endorsements, proofs, leave requests, time sheets which will be stored online, enabling restaurant owners spend less time on administrative tasks so they can focus on their customers.

NaoX Technologies

Venture Round in 2022
NaoX Technologies develops wireless headphones that listen to brain vibrations.

Ascor Communication

Venture Round in 2022
Ascor Communication, a holding company, through its subsidiaries, provides digital and distance learning solutions. The company was incorporated in 2007 and is based in Rennes, France.

Cureety

Series A in 2022
Cureety SAS develops Cureety, an interoperable application to integrate into the daily life of all healthcare establishments. It provides researchers and industrialists with real-life data sources and a range of anti-tumor treatments. The company was incorporated in 2018 and is based in Dinan, France.

Sextant

Series B in 2022
Sextant is a network of local estate agents specializing in the sale of properties in France. Established in less than a decade, the company has become a leader in its market segment by effectively leveraging real estate agent networks. Sextant develops applications and websites to enhance the efficiency of its agents and improve the overall customer experience for buyers and sellers. The company also manages all legal and financial aspects of property transactions, ensuring a straightforward and hassle-free purchasing process. Through its innovative approach, Sextant actively contributes to the development of the French Proptech sector.

Wandercraft

Series C in 2022
Wandercraft SAS, founded in 2012 and based in Paris, France, specializes in the development of exoskeleton technology aimed at patients with mobility limitations due to spinal cord injuries, neuromuscular diseases, and strokes. The company's flagship product, Atalante, is a self-balancing, hands-free exoskeleton designed for rehabilitation in health centers, allowing users to walk without the need for crutches or additional technical aids. CE-marked in 2019, Atalante is sold to European rehabilitation hospitals to enhance gait re-learning treatments. Additionally, Wandercraft is working on a more compact exoskeleton for personal mobility in everyday life. The company integrates expertise in areas such as robotics, artificial intelligence, and clinical applications, making it a pioneer in creating realistic, autonomous walking devices for individuals with walking impairments.

NAWA Technologies

Series C in 2022
NAWATECHNOLOGIES, Société anonyme designs, develops, industrializes, and commercializes products based on organized nanostructures to enable improvements in materials and devices dedicated to energy, transportation, and environment markets. The company offers multifunctional materials and energy storage devices. NAWATECHNOLOGIES, Société anonyme was founded in 2013 and is based in Aix-en-Provence, France.

Starkage Therapeutics

Venture Round in 2022
Developer a biotechnology platform intended to improve the quality of life of patients. The company's platform specializes in developing an alternate method for the depletion of senescent cells in age-related pathologies using immunotherapy with cancer therapy and senescence, enabling patients to have proper health and treatment.

Figures

Venture Round in 2022
Figures is a compensation benchmark provider, as well as a gender diversity audit tool, specifically for start-ups & scale-ups.

Exotec

Series D in 2022
Exotec Solutions, based in Croix, France, specializes in innovative order preparation systems that utilize a fleet of collaborative mobile robots. Founded in 2016, the company’s technology enhances warehouse management by employing an orders-to-man system, which brings items directly to the picker, improving efficiency in e-commerce, fast-moving consumer goods, retail, and third-party logistics applications. The Exo robots navigate without fixed infrastructure, while the Fleet Control supervisor coordinates their movements and tasks, interfacing with warehouse management systems. This system essentially functions as a virtual conveyor with limitless path options, facilitating seamless picking and dropping of goods in various logistical environments.

PayFit

Series E in 2022
Paying employees has never been easier. PayFit allows SMEs to easily manage the pay and leave of their employees. In 2015, the observation was simple: no employer was satisfied with the solutions used to manage the pay of its employees. No solution allowed a company to manage payroll quickly and without prior expertise. No solution answered automatically and securely to the French administrative complexity. There was no solution to centralize all the issues related to employee management on a single tool. No solution offered an intuitive and user-friendly interface for the employer but also for the employee.

Groupe SFC

Venture Round in 2022
• A team of 200 employees including 18 associates, providing daily guidance to more than 5000 clients • 9 locations in France • Our policy is geared towards quality and customer satisfaction • Understanding of technology which guarantees the use of high-performance and specialised solutions • Experts to drive forward your performance, at all stages of your company’s life • In 2012, turnover of close to €14.5m

Signia Therapeutics

Grant in 2022
Signia Therapeutics proposes a breakthrough strategy to identify and repurpose rapidly, efficiently and at low cost already marketed drugs or to recycle unused drugs for new antiviral indication against several human respiratory viruses. These antiviral candidates could be directly evaluated in phase II clinical trials and/or quickly available in response to any widespread outbreak for which the medical community and patients have limited options.

Pherecydes Pharma

Grant in 2022
Pherecydes Pharma SA is a biotechnology company based in Romainville, France, specializing in the research and development of lytic bacteriophages for therapeutic and diagnostic uses, with a particular emphasis on combating antibiotic resistance. Established in 2006, the company has developed a collection of bacteriophages aimed at treating various bacterial infections, including those caused by Escherichia coli. Pherecydes Pharma is currently conducting a multicenter European trial to evaluate the efficacy of phage therapy in treating infected burn wounds. The company's innovative approach involves targeting bacterial cells to inject genetic material, allowing the phages to reproduce and eliminate the bacteria. This method enables healthcare professionals to detect and address infections caused by a wide range of multi-resistant and emergent bacteria, providing a promising alternative to traditional antibiotic treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.